Lamivudine plus adefovir or telbivudine plus adefovir for chronic hepatitis B patients with suboptimal response to adefovir.
Latest Information Update: 23 Jan 2013
At a glance
- Drugs Adefovir (Primary) ; Lamivudine (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 21 May 2012 Actual end date (31 Aug 2011) added as reported by Chinese Clinical Trial Register.
- 10 Jan 2012 New trial record